Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Moderna, Inc. (MRNA) Institutional Ownership & Insider Trading

779 institutions reported holding Moderna, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 22 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MRNAModerna, Inc.Follow MRNA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
79.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
6 Nov, in 13 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

779 institutions held 79.8% of the shares. Across filers that reported both quarters, shares held changed +2.6%.

Increased+235New+110Decreased-210Closed-66

Largest moves, shares (millions)

FMR+6.2MT. Rowe Price Associates+4.9MCapital World Investors+3.6MAlyeska Investment Group-3.5MFirst Trust Advisors-2.4MGoldman Sachs Group-1.9M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-6.0Sep 24+9.3Dec 24+5.8Mar 25+9.6Jun 25-14.7Sep 25+23.8Dec 25+13.5Mar 26+8.0Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26779319+2.6%23511021066
Mar 26717308+5.4%21311218257
Dec 25662303+8.7%1466523246
Sep 25620276-5.1%1764220170
Jun 25661291+3.4%2156219075
Mar 25669279+2.1%22755181105
Dec 24713276+3.6%21165226148
Sep 24757257-2.5%23041283190

Moderna, Inc. — questions

Who owns Moderna, Inc. stock?
779 institutions reported Moderna, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (13.0%), BlackRock, Inc. (7.7%), VANGUARD CAPITAL MANAGEMENT LLC (5.8%).
Are Moderna, Inc. insiders buying or selling?
22 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Moderna, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.